Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.109976 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.109976 32563970!7276125!32563970     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 144 (ä): 109976 Nephropedia Template TP {{tp|p=32563970|t=2020. Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy |pdf=|usr=}}{{32563970}} gab.com Text Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32563970 #FOAvip Several attempts to control the dreadfulness of SARS-CoV-2 are still underway. Based on the literature evidences we have speculated a prospective contemporary remedy, which was categorized into Specificity, Remedy, and a Conveyor. In which, pros and cons were discussed and inferred the possible alternatives. (a) Specificity: Implicit to express the ACE2 receptors in conveyor cells to deceive SARS-CoV-2 frompreponetargets. (b) Remedy: As depletion of pulmonary surfactants causes strong acute respiratory distress syndrome, we propose an entity of a cost-effective artificialsurfactantsystem as a remedy to pulmonary complications. (c) Conveyor: We propose red blood cells (RBCs) as a conveyor with embedded artificial surfactant and protruding ACE2 receptors for the target-specific delivery. Overall we postulate focused insights by employing a combinational contemporary strategy to steer towards a prospective direction on combating SARS-CoV-2. Twit Text FOAVip Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32563970 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32563970 #FOAvip English Wikipedia <ref>{{Cite pmid|32563970}}</ref> Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy #MMPMID32563970 Balaji A; Bhuvaneswari S; Kumar DN Med Hypotheses 2020[Nov]; 144 (ä): 109976 PMID32563970show ga Several attempts to control the dreadfulness of SARS-CoV-2 are still underway. Based on the literature evidences we have speculated a prospective contemporary remedy, which was categorized into Specificity, Remedy, and a Conveyor. In which, pros and cons were discussed and inferred the possible alternatives. (a) Specificity: Implicit to express the ACE2 receptors in conveyor cells to deceive SARS-CoV-2 frompreponetargets. (b) Remedy: As depletion of pulmonary surfactants causes strong acute respiratory distress syndrome, we propose an entity of a cost-effective artificialsurfactantsystem as a remedy to pulmonary complications. (c) Conveyor: We propose red blood cells (RBCs) as a conveyor with embedded artificial surfactant and protruding ACE2 receptors for the target-specific delivery. Overall we postulate focused insights by employing a combinational contemporary strategy to steer towards a prospective direction on combating SARS-CoV-2. |*Erythrocytes[MESH] |*Viral Tropism[MESH] |Angiotensin-Converting Enzyme 2/administration & dosage/*therapeutic use[MESH] |COVID-19/complications/prevention & control/*virology[MESH] |Drug Costs[MESH] |Drug Delivery Systems[MESH] |Humans[MESH] |Pulmonary Alveoli/drug effects/virology[MESH] |Pulmonary Surfactants/administration & dosage/chemical synthesis/economics/*therapeutic use[MESH] |Receptors, Virus/administration & dosage/*therapeutic use[MESH] |Respiratory Distress Syndrome/prevention & control[MESH]Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemp(epmc).pdf DeepDyve Pubget Overpricing